Further, CRTC1, but not CRTC2 and CRTC3, is directly targetable and negatively regulated by miR-34a, a pathogenic microRNA upregulated in a broad spectrum of NAFLD. The gene discussed is CRTC2; the disease is metabolic dysfunction-associated steatotic liver disease.